The Resource for your Nonhuman Primate Research

We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Recent Publications Using Our Reagents...

            

Have you tried measuring anti-drug antibodies using our reagents?

Check our Anti-rhesus IgG1/3 [1B3] clone (reacts with monkey but not human IgGs!)

(also, feel free to download the NHPRR vial sticker!)

2022 January 04

Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys

Amarendra Pegu, Ling Xu, Megan E DeMouth, Giulia Fabozzi, Kylie March, Cassandra G Almasri, Michelle D Cully, Keyun Wang, Eun Sung Yang, Joana Dias, Christine M Fennessey, Jason Hataye, Ronnie R Wei, Ercole Rao, Joseph P Casazza, Wanwisa Promsote, Mangaiarkarasi Asokan, Krisha McKee, Stephen D Schmidt, Xuejun Chen, Cuiping Liu, Wei Shi, Hui Geng, Kathryn E Foulds, Shing-Fen Kao, Amy Noe, Hui Li, George M Shaw, Tongqing Zhou, Constantinos Petrovas, John-Paul Todd, Brandon F Keele, Jeffrey D Lifson, Nicole A Doria-Rose, Richard A Koup, Zhi-Yong Yang, Gary J Nabel, John R Mascola

Cell Rep

Anti-CD8 beta [CD8b255R1]

2021 December 23

Anti-thymoglobulin induction improves neonatal porcine xenoislet engraftment and survival

Gao Qimeng, Davis Robert, Fitch Zachary, Mulvihill Michael, Ezekian Brian, Schroder Paul, Schmitz Robin, Song Mingqing, Leopardi Frank, Ribeiro Marianna, Miller Allison, Moris Dimitrios, Shaw Brian, Samy Kannan, Reimann Keith, Williams Kyha, Collins Bradley, Kirk Allan

Xenotransplantation

Anti-rhesus thymocyte [rhATG] - (all lots)

2021 December 07

Production and Characterization of SIV-Specific CAR/CXCR5 T Cells

Mary S. Pampusch, Agnes Hajduczki, Gwantwa Mwakalundwa, Elizabeth Connick, Edward A. Berger, Pamela J. Skinner

Immune Receptors. Methods in Molecular Biology, vol 2421. Humana, New York, NY.

Anti-CXCR5 [710D82.1]

2021 December 03

A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity

Murillo Silva, Yu Kato, Mariane B Melo, Ivy Phung, Brian L Freeman, Zhongming Li, Kangsan Roh, Jan W Van Wijnbergen, Hannah Watkins, Chiamaka A Enemuo, Brittany L Hartwell, Jason Y H Chang, Shuhao Xiao, Kristen A Rodrigues, Kimberly M Cirelli, Na Li, Sonya Haupt, Aereas Aung, Benjamin Cossette, Wuhbet Abraham, Swati Kataria, Raiza Bastidas, Jinal Bhiman, Caitlyn Linde, Nathaniel I Bloom, Bettina Groschel, Erik Georgeson, Nicole Phelps, Ayush Thomas, Julia Bals, Diane G Carnathan, Daniel Lingwood, Dennis R Burton, Galit Alter, Timothy P Padera, Angela M Belcher, William R Schief, Guido Silvestri, Ruth M Ruprecht, Shane Crotty, Darrell J Irvine

Sci Immunol

Anti-CD38 [OKT10]-PE

News & Updates:

2022 Jan 13

RhATG Discontinuation

We will discontinue the production of rhATG in 2022. Please find the reasons behind this decision on the attached letter (PDF).

2021 Apr 02

Stabilized Spike Glycoproteins for COVID Research

We have produced stabilized Spike proteins for NIAID, now offered through BEI. Please check the details on the constructs and order them directly from beiresources.org (cat. NR-52724, NR-53937)

READ MORE

2021 Sep 07

Anti-IFNAR therapeutic antibody now available

The rhesus recombinant anti-Interferon alpha receptor (IFNAR) 1 'Anti-IFNAR [Ani]' is now available for distribution. This antibody binds to the receptor blocking the activity of type I interferons.

READ MORE

2021 Feb 15

How to Cite Our Reagents Using RRIDs

We are now using Research Resource Identifiers (RRIDs) on our entire catalog to facilitate proper antibody identification. The idea behind the use of resource identifiers is simple: citation of our antibodies (using unique RRIDs) will automatically associate specific reagents with your publication.

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.